MorphoSys AG
METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS
Last updated:
Abstract:
The present disclosure is directed to identifying characteristics and biomarkers in patients that benefit from treatment with an anti-CD19 antibody.
Status:
Application
Type:
Utility
Filling date:
25 May 2022
Issue date:
8 Sep 2022